Collegium Reports Record Fourth Quarter and Full-Year 2023 F

– Generated Record Quarterly and Full-Year Net Revenue of $149.7 Million and $566.8 Million – – Achieved Quarterly and Full-Year GAAP Net Income of $31.9 Million and $48.2 Million – ...

Related Keywords

Massachusetts , United States , Marissa Samuels , Colleen Tupper , Christopher James , Joe Ciaffoni , Corporate Communications , While The Company , Drug Administration , Nasdaq , Us Court , Us Drug Enforcement Agency , Collegium Pharmaceutical Inc , Generated Record Quarterly , Full Year Net Revenue , Achieved Quarterly , Delivered Record Quarterly , Full Year Adjusted , Cash Equivalents , Marketable Securities , Conference Call Scheduled , Chief Executive Officer , Chief Financial Officer , Patent Trial , Appeal Board , Nucynta Franchise , Product Revenues , Adjusted Operating Expenses , Excluding Stock Based Compensation , Quarter Ended December , Year Ended December , Call Information , Collegium Pharmaceutical , Net Income , Adjusted Earnings Per , Regulations K , Private Securities Litigation Reform Act , Enforcement Agency , Annual Reports , Quarterly Reports , Condensed Statements , Months Ended December , Ended December , Adjusted Operating , Adjusted Net Income , Markets ,